タンパク質キナーゼC-セータは,T細胞の機能の調節にネガティブなフィードバックを媒介する
Alexandra Zanin-Zhorov1, Yi Ding, Sudha Kumari
1Molecular Pathogenesis Program, Helen and Martin Kimmel Center for Biology and Medicine, Skirball Institute of Biomolecular Medicine, Department of Pathology, New York University School of Medicine, New York, NY 10016, USA.
まとめ
タンパク質キナーゼC-セータ (PKC-セータ) は,T細胞 (Treg) 機能の調節を阻害する. PKC-thetaを阻害すると,Tregの活性が強化され,炎症性サイトカインの存在下でTregの機能を回復することで,炎症性疾患の治療の可能性がもたらされます.
科学分野:
- 免疫学 免疫学とは
- 細胞生物学 細胞生物学
- 炎症の研究 炎症の研究
背景:
- 調節性T細胞 (Tregs) は免疫反応を制御するが,腫瘍死滅因子アルファ (TNF-alpha) によって抑制される.
- タンパク質キナーゼC-セータ (PKC-セータ) は,エフェクターT細胞 (Teff) の活性化に不可欠です.
- Treg機能におけるPKC-thetaの役割は,以前は不明でした.
研究 の 目的:
- Treg機能におけるPKC-thetaの役割と,TNF-alphaとの相互作用を調査する.
- PKC-thetaを阻害することでTregの活性が回復できるかどうかを判断する.
主な方法:
- Treg免疫シナプスのPKC-セータ局所化を研究した.
- in vitroおよびin vivoモデルでPKC-セータ阻害を利用した.
- TNF-αと疾患モデルにおいてTreg機能を評価した.
主要な成果:
- PKC-thetaはTreg免疫シナプスから隔離された.
- PKC-セータ封鎖により,Treg媒介抑制が強化された.
- TNF-α誘発の不活性化によるPKC-theta 保護されたTregsの抑制.
- リウマチ性関節炎患者のTreg機能を回復し,マウスの大腸炎に対する保護を改善しました.
結論:
- PKC-thetaはTreg機能の阻害剤として作用する.
- PKC-thetaをターゲットにすることで,Tregs.の炎症性サイトカイン阻害を克服することができます.
- PKC-セータ抑制は,炎症性疾患に対する有望な治療戦略です.
関連する概念動画
T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

